Introduction {#s1}
============

The Anatomical Therapeutic Chemical (ATC) Classification System ([@B27]), maintained by the World Health Organization Collaborating Centre for Drug Statistics Methodology, is the most widely accepted and canonical scheme for drug categorization. This system assigns different group labels for drugs based on the organ or systems where they take effect and/or their therapeutic, pharmacological, and chemical attributes. The ATC system is a strict hierarchy, including five levels of classification, and for the first level, there are 14 main groups: 1) alimentary tract and metabolism (coded by **A**); 2) blood and blood-forming organs (coded by **B**); 3) cardiovascular system (coded by **C**); 4) dermatologicals (coded by **D**); 5) genitourinary system and sex hormones (coded by **G**); 6) systemic hormonal preparations, excluding sex hormones and insulins (coded by **H**); 7) anti-infectives for systemic use (coded by **J**); 8) antineoplastic and immunomodulating agents (coded by **L**); 9) musculoskeletal system (coded by **M**); 10) nervous system (coded by **N**); 11) antiparasitic products, insecticides, and repellents (coded by **P**); 12) respiratory system (coded by **R**); 13) sensory organs (coded by **S**); and 14) various (coded by **V**). Given a new compound, prediction of its ATC classes can provide us with deeper insights into its therapeutic indications and side effects, thus accelerating both basic research and drug development ([@B20]; [@B13]).

Traditionally, identification of ATC classes for a new drug using experimental methods is both time- and resource-consuming. Therefore, *in silico* prediction of ATC classes of a compound by machine learning techniques is a hot field in drug discovery and development. Previous studies ([@B13]; [@B47]) formulate the prediction of ATC classes as a single-label learning task, which is suggested to be inappropriate due to the multilabel nature of this biological system ([@B10]). Within the multilabel learning framework, [@B9] proposed a multilabel predictor iATC-mISF, which utilized multilabel Gaussian kernel regression and three types of features (chemical--chemical interaction, structural similarity, and fingerprint similarity). The iATC-mISF has been upgraded as iATC-mHyb ([@B8]) by further incorporating drug ontological information. Besides one-dimensional representation of features, inspired by the histograms of oriented gradients (HoG) method proposed by the computer vison community ([@B12]), [@B32] reshaped the features into two-dimensional matrix and performed slightly better than iATC-mISF. Continuing in this direction, the same group ([@B26]) applied pretrained convolutional neural networks models on the two-dimensional feature matrix as a featurizer and achieved best performance among the previously published methods on this task.

Typically, multilabel (ML) classification algorithms are classified into three major groups: algorithm adaptation, problem transformation, and ensembles of multilabel classifier (EMLC) ([@B43]). Algorithm adaptation methods incorporate specific tricks that modify traditional single-label learning algorithms into multilabel ones. The representative algorithm of this group is ML-*k*NN ([@B56]). For the problem transformation method, it converts multilabel learning problem into one or more single-label problems. The common strategies for such a transformation include binary relevance, classifier chains, label ranking, and label powerset (LP) ([@B37]). LP trains models on each possible subset of label sets ([@B16]). For a dataset with high cardinality in the large label set, LP is prone to be overfitting because of the exponentially increased number of subsets. To tackle the overfitting nature of label powerset, ([@B42]) proposed the RA*k*EL*d* method, which divides the label set into *k* disjoint subsets and use label powerset in these subsets. One major drawback of RA*k*EL*d* is that the *k* is arbitrarily chosen without incorporating the label correlations, which can be possibly learnt from the training data. The **n**etwork-based **l**abel **s**pace **p**artition (NLSP) ([@B41]) is an EMLC built upon ML. This NLSP method divides the label set into *k* small-sized label sets (possibly intersecting) by a community detection method, which can incorporate the label correlation structures in the training set, such that it finally learns *k* representative ML classifiers. As a result, NLSP tackles much less subsets compared to LP on the original label set and selects *k* in a data-driven manner. For more detailed explanation of multilabel learning, refer to ([@B57]; [@B31]).

In this study, we adopted an NLSP method to explore the correlation among labels. Our NLSP method was evaluated on a benchmark dataset ([@B7]) by the jackknife test. The proposed method demonstrates its superiority over other state-of-the-art approaches by our experimental results. The main strength of our method hinges on two aspects. On the one hand, the NLSP clusters the label space into subspaces and utilizes the correlation among labels. On the other hand, the ensemble learning nature of NLSP on the overlapping subspace could further improve model performance. Interesting patterns on the label relation graph were also detected by NLSP. In addition, the label-wise analysis of the best NLSP model was performed to provide experimental biologists with more insights.

Materials and Methods {#s2}
=====================

Benchmark Dataset and Sample Formulation {#s2_1}
----------------------------------------

We utilized the same dataset as the previous study ([@B9]) to facilitate model comparison. This dataset consists of 3,883 drugs, and each drug is labeled with at least one or more of 14 main ATC classes. It is a tidy dataset where no missing value and contradictory record. The UpSet visualization technique ([@B23]) was used for quantitative analysis of interactions of label sets.

Then, we adopted the same method provided by ([@B9]) to represent the drug samples. The dataset can be formulated in set notation as the union of elements in each class: $\mathbb{S} = \mathbb{S}_{1} \cup \mathbb{S}_{2}\ldots \cup \mathbb{S}_{14}$ (1), and a sample *D* can be represented by concatenating the following three types of features.

1.  A 14-dimentional vector, *D* **^Int^** = \[Φ~1~Φ~2~Φ~3~ ... Φ~14~\]*^T^* (2), which represents its maximum interaction score Φ*~i~* ([@B22]) with the drugs in each of the 14 $\mathbb{S}_{i}$.

2.  A 14-dimentional vector, *D* **^StrSim^** = \[Ψ~1~Ψ~2~Ψ~3~ ~...~ Ψ~14~\]*^T^* (3) which represents its maximum structural similarity score Ψ*~i~* ([@B22]) with the drugs in each of the 14 $\mathbb{S}_{i}$.

3.  A 14-dimentional vector, *D* **^FigSim^** = \[T~1~T~2~T~3~ ... T~14~\]*^T^* (4), which represents its molecular fingerprint similarity score T*~i~* ([@B48]) with the drugs in each of the 14 $\mathbb{S}_{i}$.

Therefore, a given drug *D* is formulated by:
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For more details, refer to [@B9].

Measuring Label Correlation {#s2_2}
---------------------------

In order to evaluate the correlation between two labels, we calculated the bias corrected Cramér's V statistic for all the label pairs ([@B1]). Cramér's V (sometimes referred to as Cramér's phi and denoted as ϕc) statistic is a measure of association between two nominal variables, ranging from 0 to 1 (inclusive). The bias corrected Cramér's V statistic is given by (here *n* denotes sample size and *χ*^2^ stands for the chi-square statistic without a continuity correction for a contingency table with *r* rows and *c* columns)

V

˜

=

φ

˜

2

m

˜

where

φ

˜

2

=

max

⁡

(

0

,

φ

2

−

(

r

−

1

)

(

c

−

1

)

n

−

1

)

)

φ

2

=

χ

2

n

and

m

˜

=

min

⁡

(

r

˜

−

1

,

c

˜

−

1

)

r

˜

=

r

−

(

(

r

−

1

)

2

n

−

1

)

c

˜

=

c

−

(

(

c

−

1

)

2

n

−

1

)

Network-Based Label Space Partition {#s2_3}
-----------------------------------

The NLSP is a newly proposed multilabel learning method and has achieved top performance in some predictive tasks ([@B41]). In this study, we adopted the data-driven NLSP method for prediction of ATC classes of a compound. NLSP divides the predictive modeling task into the training and classification phase.

In the training phase, four steps are preformed:

13. Establishing a label co-occurrence graph on the training set. The label co-occurrence graph *G* has the label set *L* as the vertex set and the edge between two vertices (labels) exists if at least one sample *S* in training set *D* *~train~* is assigned by these two labels *l* *~i~* and *l* *~j~* together (here *l* *~i~*, *l* *~j~* denote labels of the set *L* *~s~*, which stands for the assigned label set of a sample *S*; \|\| \|\| stands for the cardinality of a given set): $$E = \left\{ {\left\{ l_{i},l_{j} \right\}:(\exists(S,L_{s}) \in D_{\mathit{train}})\left( {l_{i} \in L_{s} \land l_{j} \in L_{s}} \right)} \right\}$$

    We can also easily assign weights to *G* by defining a counting function *w*: *L* → ℕ: $$\begin{matrix}
    {w\left( {l_{i},l_{j}} \right) = \text{number~of~sample~}S\text{~that~have~both~labels~assigned}} \\
    {\phantom{w\left( {l_{i},l_{j}} \right)}{= \left\| \left\{ {S:(S,L_{s}) \in \text{D}_{\mathit{train}} \land l_{i} \in L_{s} \land l_{j} \in L_{s}} \right\} \right\|}} \\
    \end{matrix}$$

14. Detecting community on the label co-occurrence graph. There are various community detection algorithms. In this study, we utilized the following two methods to identify communities because both of the two methods have linear time complexity:

    a.  **Largest modularity using incremental greedy search (Louvain method)** ([@B3]): This method is based on greedy aggregation of communities, beginning with communities with single convex and merging the communities iteratively. In each step, two communities are merged when the merging makes the highest contribution to modularity. The algorithm halts when there is no merge that could increase current modularity. This method is frequently referred as "Louvain method" in the network research community. The detailed explanation of this method is described in [**Supplementary Method S1**](#SM1){ref-type="supplementary-material"}.

    b.  **Multiple async label propagation (LPA)** ([@B36]): This method assigns unique tags to every vertex in a graph and then iteratively updates the tags of every vertex. This update reassigns the tag of the majority of neighbors to the central vertex. The updating order of vertices shuffled at each iteration. The algorithm is stopped when all vertices have tags identical to the dominant tag in proximity. The detailed description of LPA is appended in [**Supplementary Method S2**](#SM1){ref-type="supplementary-material"}.

15. For each community *C* *~i~*, corresponding training set *D* *~i~* is created by taking the original dataset with label columns presented in *L* *~i~*.

16. For each community, a base predictor *b* *~i~* is learnt on the training set *D* *~i~*. In this study, we compared the performance of five types of base predictors:

    a.  **Extremely randomized trees (ERT)** ([@B15]; [@B25]) is an ensemble method that adds more randomness compared to random forests by the random top--down splitting of trees instead of computing the locally optimal cut-point for each feature under consideration. This increase in randomness allows to reduce the variance of the model a bit, at the expense of a slightly greater increase in bias.

    b.  **Random forests (RF)** ([@B4]) is an ensemble method that combines the probabilistic predictions of a number of decision tree-based classifiers to improve the generalization ability over a single estimator.

    c.  **Support vector machine (SVM)** ([@B11]) is a widely used classification algorithm which tries to find the maximum margin hyperplane to divide samples into different classes. Incorporated by kernel trick, this method could handle both linear and no-linear decision boundary.

    d.  **Extreme gradient boosting (XGB)** ([@B5]) is a newly proposed boosting method, which has achieved state-of-the-art performance on many tasks with tabular training data ([@B6]). Traditional gradient boosting machine is a meta algorithm to build an ensemble strong learner from weak learners such as decision trees, while XGB is an efficient and distributed implementation of gradient boosting machine.

    e.  **Multilayer perceptron (MLP)** ([@B38]) is a supervised learning algorithm which could learn nonlinear models. It has one or more nonlinear hidden layers between the input and output. For each hidden layer, different numbers of hidden neurons can be assigned. Each hidden neuron yields a weighted linear summation of the values from the previous layer, and the nonlinear activation function is followed. The weights are learnt through backpropagation algorithm or variations upon it.

In the classification phase, we just perform predication on all communities detected in the training phase and fetch the union of assigned labels:
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Parameter Tuning {#s2_4}
----------------

There are two layers of hyperparameters tunable for NLSP:

1.  The base learner: we chose five types of base learners.

    a.  Extremely randomized trees: we tuned the hyperparameter of number of trees at \[500, 1000\], other hyperparameters are at the default values.

    b.  Random forests: we tuned hyperparameter of number of trees at \[500, 1,000\], other hyperparameters are at the default values.

    c.  Support vector machine: we tuned the hyperparameter of *C* (penalty) at \[0.01, 0.1, 1, 10, 100\], we chose the radial basis function with gamma value of $\frac{1}{N_{features}} = \frac{1}{42},$ other hyperparameters are at the default values.

    d.  Extreme gradient boosting: we tuned the hyperparameter of number of trees at \[10, 20, 30, 40, 50, 60, 70, 80, 90, 100\], other hyperparameters are at the default values.

    e.  Multilayer perceptron: We tuned the hyperparameter of hidden layer sizes at \[50, 100, 200, 500, 1,000\], other hyperparameters are at the default values.

2.  The cluster: for each type of base learner, we try to compare two community detection methods.

    a.  Largest modularity using incremental greedy search ([@B3]).

    b.  Multiple async label propagation ([@B36]).

Performance Measures of Multilabel Learning {#s2_5}
-------------------------------------------

Evaluation of a multilabel learning model is not a trivial task ([@B58]; [@B55]; [@B60]; [@B54]; [@B49]; [@B53]). Inspired by the definition of Chou *et al.* ([@B10]) and practice of [@B28], we utilized the following five metrics to evaluate the multilabel learning models throughout this work.
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where *N* is the total number of samples, *M* is the total number of labels, ⋃ represents union in set theory and ⋂ represents intersection in set theory, $\mathbb{L}_{k}$ denotes the true label set of *k*-th sample, $\mathbb{L}_{k}^{*}$ means the predicted label vector of *k*-th sample, ⊝ stands for the symmetric difference between two sets, and
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In order to avoid the zero-divisor problem generated by all negative predictions, we add a pseudo-number 1 to 0 divisors in the calculation of the aiming metric. These above metrics have been used in a series of studies ([@B8]; [@B9]; [@B32]).

Performance Measures of Single-Label Learning {#s2_6}
---------------------------------------------

Apart from the metrics in the multilabel framework, we also utilized the following metrics to assess the single-label classification models.
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where *TP*, *TN*, *FN*, and *TN* are true positives, true negatives, false positives, and false negatives for the prediction of each label, respectively. These metrics have widely been used in a large number of bioinformatics applications recently ([@B14]; [@B33]; [@B39]; [@B44]; [@B51]; [@B18]; [@B24]; [@B34]; [@B35]; [@B50]; [@B52]; [@B59]; [@B2]; [@B45]; [@B46]; [@B61]). In addition, we also calculated the area under the receive operating characteristic curve (AUC) by the trapezoidal rule.

Model Validation Method {#s2_7}
-----------------------

There are mainly three methods to evaluate the generalization ability of a classification model, such as the independent testing method, *k*-fold cross validation, and the jackknife method. In order to fairly compare our proposed model with previous works on the same benchmark dataset, we utilized the jackknife method for the model validation in the multilabel learning framework. Jackknife is a resampling method for parameter estimation. The jackknife estimation of a parameter is constructed by calculating the parameter for each subsample omitting the *i*-th observation and then takes the mean value of these parameters as final estimation.

In the model validation of single-label analysis, we utilized 10 times repeated 10-fold cross validation (10 × 10-fold CV) method. In *k*-fold cross validation (CV), the sample set is randomly partitioned into *k* subsets with equal size. Of the *k* subsets, one subset is selected as the validation data for testing the model, and the remaining *k* − 1 subsets are used for training. The cross-validation process is then repeated *k* times (the folds), with each of the *k* subsets used exactly once as the validation data. The 10-fold cross-validation is proven to be a better alternative of jackknife method in terms of bias, variance, and computation complexity ([@B21]). We also repeated 10-fold CV 10 times in shuffled benchmark dataset to further reduce the estimation variance.

Results and Discussion {#s3}
======================

Label Correlation Analysis {#s3_1}
--------------------------

One major advantage of multilabel learning framework is the explicit exploitation of label correlations ([@B57]). We calculated bias corrected Cramér's V statistics for all the label pairs and depicted them in a heatmap manner ([**Figure 1A**](#f1){ref-type="fig"}), and the UpSet visualization of label intersections is depicted in [**Figure 1B**](#f1){ref-type="fig"}. The results indicated that 46 drugs are both labeled as ATC category 4 (dermatologicals) and ATC category 12 (respiratory system), 43 drugs are both labeled as ATC category 13 (sensory organs) and ATC category 7 (anti-infectives for systemic use), which can be explained by the fact that many widely applied corticosteroids, such as dexamethasone, betamethasone, and fluocortolone, can be used both in dermatology and respirology medicine. We also found that several label sets are correlated, especially for ATC category 4 (dermatologicals) and ATC category 13 (sensory organs), of which the Cramér's V statistic is 0.29. Details about the pairwise intersection numbers of drugs and the pairwise Cramér's V statistics between all the labels are shown in [**Table S1**](#SM1){ref-type="supplementary-material"} and [**Table S2**](#SM1){ref-type="supplementary-material"}.

![Label correlation landscape. **(A)** The pair wise visualization of Cramér's V statistics for all the labels in a heatmap manner. **(B)** The UpSet visualization of label intersections. The horizontal bar shows the number of drugs per ATC category, and the vertical bar shows the number of drugs per ATC category intersection.](fphar-10-00971-g001){#f1}

Multilabel Performance Comparison {#s3_2}
---------------------------------

[**Table 1**](#T1){ref-type="table"} shows the prediction performances based on the jackknife test among different methods on the benchmark dataset. We found the absolute true value of almost all our NLSP-based methods performed better than that of other methods, which is the most stringent metric for multilabel learning. Among all the NLSP-based models, the NLSP-XGB-LPA performs the best, consistently better than all the other methods trained on benchmark dataset, in terms of aiming, coverage, accuracy, and absolute true. As for the value of absolute true, our NLSP-XGB-LPA has boosted ∼11.67% compared to the best deep learning model trained on the same benchmark dataset ([@B26]). As for the clusterer, we found that the LPA method performs consistently better than the Louvain method in all the NLSP-based models ([**Figure S1**](#SM1){ref-type="supplementary-material"}), so we append the suffix of "-LPA" to all the NLSP-based models. We then trained the final NLSP-XGB-LPA model on the full benchmark dataset using previous optimized hyperparameters. This model can be accessed through <https://github.com/dqwei-lab/ATC>.

###### 

Comparison with other state-of-the-art multilabel predictors.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Method                                                           DL[^a^](#fnT1_1){ref-type="table-fn"}   Aiming                                          Coverage     Accuracy     Absolute true   Hamming loss
  ---------------------------------------------------------------- --------------------------------------- ----------------------------------------------- ------------ ------------ --------------- ---------------
  EnsANet_LR ⊕ DO[^c^](#fnT1_3){ref-type="table-fn"} (τ = 0.25)\   Yes                                     0.7957                                          0.8335       0.7778       0.7090          Not available
  ([@B26])                                                                                                                                                                                           

  EnsANet_LR ⊕DO[^c^](#fnT1_3){ref-type="table-fn"} (τ = 0.5)\     Yes                                     0.9011                                          0.7162       0.7232       0.6871          
  ([@B26])                                                                                                                                                                                           

  EnsLIFT\                                                         No                                      0.7818                                          0.7577       0.7121       0.6330          
  ([@B32])                                                                                                                                                                                           

  iATC-mHyb[^c^](#fnT1_3){ref-type="table-fn"}\                    No                                      0.7191                                          0.7146       0.7132       0.6675          
  ([@B8])                                                                                                                                                                                            

  Chen et al.\                                                     No                                      0.5076                                          0.7579       0.4938       0.1383          
  ([@B7])                                                                                                                                                                                            

  iATC-mISF\                                                       No                                      0.6783                                          0.6710       0.6641       0.6098          
  ([@B9])                                                                                                                                                                                            

  NLSP-ERT-LPA                                                     No                                      0.7948                                          0.7691       0.7578       0.7213          0.03817

  NLSP-RF-LPA                                                      No                                      0.8072                                          0.7889       0.7778       0.7489          **0.03427**

  NLSP-SVM-LPA                                                     No                                      0.7844                                          0.7529       0.7370       0.6925          0.04322

  NLSP-XGB-LPA                                                     No                                      **0.8135[^b^](#fnT1_2){ref-type="table-fn"}**   **0.7950**   **0.7828**   **0.7497**      0.03429

  NLSP-MLP-LPA                                                     No                                      0.7958                                          0.7858       0.7591       0.7090          0.04032
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DL denotes whether this model is a deep learning-based method.

The bold value stads for the best value of specific metrics.

These models are trained on a modified benchmark dataset, whose metrics are not comparable to our model.

Label Community Analysis {#s3_3}
------------------------

One major innovation of NLSP method is the construction of label relation graph, which is built on the concept of label co-occurrence ([@B40]). The communities detected in the label relation graph will not only help to improve the classification performance but also provide us with deeper insights of the intrinsic label structure. We extracted the community membership information from the final model of NLSP-XGB-LPA (shown in [**Figure 2**](#f2){ref-type="fig"}). We found that there are two communities detected, in which ATC category 8 (anti-infectives for systemic use) lies in a unique community. In terms of medicinal chemistry and clinical pharmacotherapeutics, anti-infectives for systemic use are structure variant and usage limited compared to other 16 types of drugs. For example, daptomycin (DB00080) is one of the anti-infectives for systemic use, which is composed of an unusual molecular structure of lipopeptide with limited indications for skin and skin structure infections caused by Gram-positive infections, *S. aureus* bacteremia, and right-sided *S. aureus* endocarditis ([@B19]). The community membership learnt from benchmark dataset is surprising but intuitive. This result suggests the potential pattern extraction power of network-based machine learning models in terms of pharmacology.

![Label relation graph. Different colors stand for different communities. The line width represents the weight between two labels. Communities are detected by multiple async label propagation method, while the weight represents the frequency of label co-occurrence.](fphar-10-00971-g002){#f2}

Single-Label Analysis {#s3_4}
---------------------

Apart from multilabel learning metrics, it is often useful to evaluate multilabel learning models in a label-wise manner ([@B30]; [@B29]). We utilized the parameters of the best-performing model of NLSP-XGB-LPA and conducted 10 times repeated 10-fold cross-validation (10 × 10-fold CV) because the jackknife test is rather time consuming. The details are listed in [**Table 2**](#T2){ref-type="table"}. We found that our NLSP-XGB-LPA performs well in all the single-label subtasks of ATC prediction, especially for the label of "anti-infectives for systemic use," reaching an AUC at 0.9946. Compared to a dedicated single-label classification system for cardiovascular system ([@B17]), our best-performing multilabel model boosted the value of accuracy from 0.8947 into 0.9490.

###### 

Label-wise analysis of best-performing multilabel learning model.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Predictive label                                      Accuracy                                        Specificity     Recall                F1 score     AUC          Evaluation method
  ----------------------------------------------------- ----------------------------------------------- --------------- --------------------- ------------ ------------ -------------------
  Alimentary tract and metabolism                       0.9269                                          0.7312          0.7549                0.7406       0.9550       10 × 10-fold CV

  Blood and blood forming organs                        0.9793                                          0.7754          0.5644                0.6430       0.9493       10 × 10-fold CV

  Cardiovascular system                                 0.9490                                          0.8371          0.8274                0.8306       0.9752       10 × 10-fold CV

  Dermatologicals                                       0.9403                                          0.7966          0.6038                0.6845       0.9472       10 × 10-fold CV

  Genitourinary system and sex hormones                 0.9691                                          0.8148          0.6682                0.7294       0.9539       10 × 10-fold CV

  Systemic hormonal preparations, excluding sex\        **0.9867[^a^](#fnT2_1){ref-type="table-fn"}**   0.8227          0.7605                0.7816       0.9940       10 × 10-fold CV
  hormones and insulins                                                                                                                                                 

  Anti-infectives for systemic use                      0.9793                                          **0.9276**      **0.9170**            **0.9215**   **0.9946**   10 × 10-fold CV

  Antineoplastic and immunomodulating agents            0.9792                                          0.8683          0.7724                0.8126       0.9804       10 × 10-fold CV

  Musculoskeletal system                                0.9820                                          0.8707          0.7836                0.8209       0.9842       10 × 10-fold CV

  Nervous system                                        0.9511                                          0.8581          0.8913                0.8733       0.9825       10 × 10-fold CV

  Antiparasitic products, insecticides and repellents   0.9863                                          0.8312          0.7358                0.7714       0.9803       10 × 10-fold CV

  Respiratory system                                    0.9573                                          0.8432          0.7516                0.7923       0.9720       10 × 10-fold CV

  Sensory organs                                        0.9492                                          0.8206          0.6367                0.7140       0.9487       10 × 10-fold CV

  Various                                               0.9717                                          0.7681          0.6997                0.7241       0.9703       10 × 10-fold CV

  Cardiovascular system\                                0.8947                                          Not available   100 × bootstrapping                             
  ([@B17])                                                                                                                                                              

  Cardiovascular system\                                0.7712                                          Test set                                                        
  ([@B17])                                                                                                                                                              

  SuperPred ([@B13])                                    0.676[^b^](#fnT2_2){ref-type="table-fn"}        Jackknife                                                       
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The bold value stands for the best value of specific metrics.

The mean accuracy of flattened 850 ATC classes.

Conclusion {#s4}
==========

Based upon the NLSP method, we have achieved the state-of-the-art performance on the benchmark dataset using the similarity-based features such as chemical--chemical interaction and structural and fingerprint similarities of a compound to other compounds belonging to the different ATC categories. Label community and single-label analysis were also performed on the benchmark dataset. There are three major conclusions can be reached. First, compared to dedicated single-label models ([@B13]; [@B17]), multilabel learning framework could improve the performance on single-label metrics by incorporating label correlation information. Second, compared to feature engineering tricks ([@B32]; [@B26]), the introduction of new method such as NLSP could generate more performance improvement. Third, at least in the ATC prediction task, the NLSP method, which adopts ideas from network research community and captures the correlation of labels in a data-driven manner, can perform better than the models based on deep learning techniques, especially in the absolute true rate metric. The idea behind NLSP method is fascinating, and the power of NLSP remains to be unleashed for the multilabel learning tasks in drug discovery.

Although the NLSP method was the first time to be applied to the multilabel classification task in pharmacology and achieved good performance in the preliminary results, there are shortcomings in several aspects in this study. First, the similarity-based features are not recalculated for the specific communities detected by the NLSP methods. Second, the rigidity of the model validation can be improved by the independent external dataset. Last but not the least, the number of communities detected by NLSP on this drug classification problem is too low, which may be not an ideal dataset for proving the predictive power of the NLSP-based method. These problems can be addressed in the further studies.
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